Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Novel rheumatic disease treatment strategy discussed at EULAR congress

June 9, 1999

Novel marine metabolite has antiinflammatory properties

June 9, 1999

Antifibroproliferative agents emerge from FibroGen/Zeneca collaboration

June 8, 1999

Small-molecule inhibitors of proinflammatory cytokines developed at Boehringer Ingelheim

June 8, 1999

D2E7 plus methotrexate: a safe and effective treatment for rheumatoid arthritis

June 8, 1999

Merck Frosst investigates alternatives to conventional NSAIDs

June 8, 1999

EULAR meeting highlights: overview of clinical experience with Reumacon

June 8, 1999

In vitro studies shed light on the mechanism of action of triptolide

June 7, 1999

Lornoxicam available in Germany for arthritic conditions

June 7, 1999

Idec presents interim phase I/II results with clenoliximab at EULAR congress

June 7, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...